Abstract:Aim: After neoadjuvant chemotherapy (NACT), tumor shrinkage pattern is a more reasonable outcome to decide a possible breast-conserving surgery (BCS) than pathological complete response (pCR). The aim of this article was to establish a machine learning model combining radiomics features from multiparametric MRI (mpMRI) and clinicopathologic characteristics, for early prediction of tumor shrinkage pattern prior to NACT in breast cancer. Materials and Methods: This study included 199 patients with breast cancer who successfully completed NACT and underwent following breast surgery. For each patient, 4,198 radiomics features were extracted from the segmented 3D regions of interest (ROI) in mpMRI sequences such as T1-weighted dynamic contrast-enhanced imaging (T1-DCE), fat-suppressed T2-weighted imaging (T2WI), and apparent diffusion coefficient (ADC) map. The feature selection and supervised machine learning algorithms were used to identify the predictors correlated with tumor shrinkage pattern as follows: (1) reducing the feature dimension by using ANOVA and the least absolute shrinkage and selection operator (LASSO) with 10-fold cross-validation, (2) splitting the dataset into a training dataset and testing dataset, and constructing prediction models using 12 classification algorithms, and (3) assessing the model performance through an area under the curve (AUC), accuracy, sensitivity, and specificity. We also compared the most discriminative model in different molecular subtypes of breast cancer. Results: The Multilayer Perception (MLP) neural network achieved higher AUC and accuracy than other classifiers. The radiomics model achieved a mean AUC of 0.975 (accuracy = 0.912) on the training dataset and 0.900 (accuracy = 0.828) on the testing dataset with 30-round 6-fold cross-validation. When incorporating clinicopathologic characteristics, the mean AUC was 0.985 (accuracy = 0.930) on the training dataset and 0.939 (accuracy = 0.870) on the testing dataset. The model further achieved good AUC on the testing dataset with 30-round 5-fold cross-validation in three molecular subtypes of breast cancer as following: (1) HR+/HER2–: 0.901 (accuracy = 0.816), (2) HER2+: 0.940 (accuracy = 0.865), and (3) TN: 0.837 (accuracy = 0.811). Conclusions: It is feasible that our machine learning model combining radiomics features and clinical characteristics could provide a potential tool to predict tumor shrinkage patterns prior to NACT. Our prediction model will be valuable in guiding NACT and surgical treatment in breast cancer.

Predicting Reduction Mammaplasty Total Resection Weight With Machine Learning

"Identifying complication risk factors in reduction mammaplasty: a single-center analysis of 1021 patients applying machine learning methods"

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Development and Assessment of Machine Learning Models for Individualized Risk Assessment of Mastectomy Skin Flap Necrosis

Breast Cancer Prediction Based on Machine Learning

Machine Learning Demonstrates High Accuracy for Disease Diagnosis and Prognosis in Plastic Surgery

Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer

Accuracy Assessment of Machine Learning Algorithms Used to Predict Breast Cancer

Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer

Development and Evaluation of a Machine Learning Prediction Model for Flap Failure in Microvascular Breast Reconstruction

Prediction of Breast Cancer using Machine Learning Approaches

The use of machine learning for predicating complications of free flap head and neck reconstruction.

Breast Cancer Prediction Based on Multiple Machine Learning Algorithms

Breast Cancer Prognosis Using a Machine Learning Approach

Breast Cancer Surgery 10-Year Survival Prediction by Machine Learning: A Large Prospective Cohort Study

Machine Learning Techniques for Breast Cancer Prediction

Machine Learning Approach towards Mammographic Breast Density Measurement for Breast Cancer Risk Prediction: An Overview

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods

Metastatic Breast Cancer Prognostication Through Multimodal Integration of Dimensionality Reduction Algorithms and Classification Algorithms

Development of Machine Learning Models for Predicting the 1‐Year Risk of Reoperation After Lower Limb Oncological Resection and Endoprosthetic Reconstruction Based on Data From the PARITY Trial

Predicting Breast Cancer Relapse from Histopathological Images with Ensemble Machine Learning Models